30 Day Survey
*
Please use the scale: 1=Much less, 2=Less, 3=The same amount, 4=More, 5=Much more, N/A=Not applicable to me
12345NA
Review the pathogenesis of asthma, including the role of biomarkers.
Evaluate current and emerging targeted and biologic therapies for the treatment of moderate-to-severe asthma presented at CHEST 2016.
Incorporate patient education into individualized treatment plans to improve patient adherence and overall quality of life for patients with moderate-to-severe asthma
*
Please use the scale: 1=Much less, 2=Less, 3=The same amount, 4=More, 5=Much more, N/A=Not applicable to me
12345NA
Utilize up-to-date asthma management guidelines to evaluate patient development.
Apply clinical trial data to patients with asthma to assess the efficacy and safety of new and emerging therapies.
Implement the practice of understanding the mechanism of action in patients with moderate-to-severe persistent asthma to apply precise personalized treatment plans.